Atlas Trials

Aliskiren in Combination With Losartan Compared to Losartan on the Regression of Left Ventricular Hypertrophy in Overweight Patients With Essential Hypertension

Clinical trial NCT00219141 · COMPLETED

Trial details

NCT number
NCT00219141
Sponsor
Novartis Pharmaceuticals
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
HypertensionLeft Ventricular HypertrophyOverweight
Start date
2005-10-01
Primary completion
2007-11-01
Enrollment
460

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.